Floatz logo

Elcubragistat

Neuromyelitis Optica

Abide TherapeuticsSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Neuromyelitis Optica cohort.

Asset / SponsorPhaseRating
Cytarabine
Fred Hutchinson Cancer Center
Phase 2CCC
Melphalan
Fred Hutchinson Cancer Center
Phase 2CCC
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
Etoposide
Fred Hutchinson Cancer Center
Phase 2CCC
Prednisone
Fred Hutchinson Cancer Center
Phase 2CCC

View all 20 →

Same molecule, other indications

Elcubragistat is also rated in:

transverse myelitisDormant
CC
Indicative · Phase 1
47 / 100
View asset →
diabetic neuropathyDormant
CC
Indicative · Phase 1
47 / 100
View asset →
postherpetic neuralgiaDormant
CC
Indicative · Phase 1
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →